Supporting the

Neuroendocrine Cancer Community

New Age for Nuclear Medicine

Dec 19, 2019

NEW AGE FOR NUCLEAR MEDICINE

Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen.

Recent News

NICE Approve SIRT Therapy for neuroendocrine tumours

We are delighted to share with you the news that NICE has approved SIRT (selective internal radiation therapy) for the treatment of neuroendocrine tumour-related liver metastases. NICE Interventional procedures guidance [IPG786]: Selective internal radiation therapy...

read more